Researchers have found that the absence or presence of microhematuria does not accurately predict whether a distal ureteral stone is still present or has passed, according to a report in the Journal of Endourology (2008;22:1233-1236).

The lower the testosterone level achieved in men undergoing androgen deprivation therapy (ADT) for advanced prostate cancer, the better their chances of survival, an Italian study found.

NEW ORLEANS—Microalbuminuria is a biomarker for vascular disease and warrants aggressive treatment, which may prevent progression to overt nephropathy and reduce the risk of cardiovascular events, said Debjani Mukherjee, MD, at the 23rd scientific meeting of the American Society of Hypertension.

WASHINGTON, D.C.—Diabetics with neuropathy use more health- care resources than diabetics without this complication. In addition, among patients with diabetic neuropathy, those with comorbid de-pression or anxiety incur higher health-care costs than patients without these psychological problems.

ORLANDO—Serum cholesterol levels may have a role in prostate biology, according to a study.

CHICAGO—The first randomized trial to evaluate the long-term outcome of a single dose of chemotherapy for early-stage testicular tumors suggests that this approach is safe and effective compared with radiation therapy, the current standard of care.

EXTRACORPOREAL SHOCK wave therapy (ESWT) may hold promise as a treatment for chronic pelvic pain syndrome (CPPS), researchers reported in BJU International (2008; online ahead of print).

CHICAGO—Sagopilone, the first in a new class of microtubule stabilizer drugs, may be effective as part of first-line treatment for men with metastatic androgen-independent prostate cancer (AIPC), researchers say.

ORLANDO—Researchers have succeeded in regenerating an entire urinary bladder in large mammals, according to new study findings presented here at the American Urological Association annual meeting

TORONTO—Women who become pregnant in the first or second year after kidney transplantation are placing themselves at a significant risk of graft loss, a study of data from the United States Renal Data System (USRDS) has confirmed.